The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 345:1641-1643 November 29, 2001 Number 22
NextNext

Coronary-Artery Bypass Surgery versus Stenting for Multivessel Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In a trial comparing coronary-artery bypass surgery with stenting for the treatment of multivessel coronary disease, Serruys et al. (April 12 issue)1 conclude that both treatments offer protection against death, stroke, and myocardial infarction. We disagree. Whether there is "protection" can be determined only through comparison with a group of patients who are assigned to medical therapy alone.

To date, no clinical trial comparing angioplasty with medical therapy for angina has demonstrated a protective effect of angioplasty in multivessel disease.2,3 Indeed, in the second Randomised Intervention Treatment of Angina (RITA-2) trial,3 patients who underwent angioplasty had a . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.